证券记录 · 已归档季度
IQV
IQVIA Holdings Inc. · Healthcare · Medical - Diagnostics & Research
21被追踪持有人
+1Δ持有人
31.11M持有股份
$6.11B报告持仓市值
+1新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +5.0% ·
股份流向 +13.6% ·
净新建仓位 +4.8%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 393.01K | $104.01M | n/a | −2 |
| Q2 2026 | 164 | +9 | 122.10M | $23.56B | +12 | −4 |
| Q1 2026 | 159 | -11 | 122.65M | $21.04B | +3 | −15 |
| Q4 2025 | 169 | +1 | 132.77M | $29.93B | +3 | −1 |
| Q3 2025 | 26 | -1 | 77.42M | $14.69B | +1 | −3 |
| Q2 2025 | 25 | +2 | 68.72M | $10.83B | +2 | n/a |
| Q1 2025 | 20 | -1 | 30.89M | $5.44B | n/a | −1 |
| Q4 2024 | 21 | +1 | 31.11M | $6.11B | +1 | n/a |
| Q3 2024 | 19 | -1 | 19.49M | $4.61B | +1 | −2 |
| Q2 2024 | 20 | n/a | 21.58M | $4.56B | n/a | n/a |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Harris Associates (Oakmark) ✦ | 11.34M | +11.4% | $2.23B | 3.7% | ▲ Add | 3 | SEC ↗ ×2 |
| 2 | State Street Global Advisors ✦ (被动) | 7.88M | n/a | $1.55B | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 4.18M | +1.9% | $818.31M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (被动) | 1.71M | +1.3% | $336.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Millennium Management ✦ | 1.37M | +301.6% | $269.33M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 965.30K | +211.2% | $189.69M | 0.2% | ▲ Add | 3 | SEC ↗ ×2 |
| 7 | Marshall Wace ✦ | 954.29K | +85.4% | $187.53M | 0.2% | ▲ Add | 3 | SEC ↗ ×3 |
| 8 | Two Sigma Investments ✦ | 767.98K | +98.4% | $150.92M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 9 | Capital World Investors ✦ | 587.87K | -11.8% | $115.52M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 427.24K | +125.3% | $83.96M | 0.1% | ▲ Add | 3 | SEC ↗ ×5 |
| 11 | PRIMECAP Management ✦ | 294.99K | -9.5% | $57.97M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 288.51K | -30.1% | $56.70M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 13 | Citadel Advisors ✦ | 87.94K | -37.0% | $17.28M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Markel Group ✦ | 58.73K | 0.0% | $11.54M | 0.1% | Held | 3 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 46.85K | -26.3% | $9.21M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Adage Capital Partners ✦ | 38.86K | +63.7% | $7.64M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Arrowstreet Capital ✦ | 37.76K | -21.8% | $7.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 31.36K | +11.8% | $6.16M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 19 | Duquesne Family Office ✦ | 21.50K | 新增 | $4.22M | 0.1% | New | 1 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 15.70K | +112.2% | $3.08M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | Wellington Management ✦ | 9.79K | +12.7% | $1.92M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Duquesne Family Office | $4.22M | 0.1% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,061 持有人, 150.48M 股份, $24.99B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 02
Berkshire James G.
Officer · 2.67K 股 · $697,228
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据